Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis

Investigational New Drugs

Volumn 27, Issue 3, 2009, Pages 233-240

  Ramakrishnan, Gopalakrishnan ^a   Jagan, Sundaram ^a   Kamaraj, Sattu ^a   Anandakumar, Pandi ^a   Devaki, Thiruvengadam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Hepatocellular carcinoma; Mast cell; MMP 2; MMP 9; N Nitrosodiethylamine; Silymarin

Indexed keywords

DIETHYLNITROSAMINE; GELATINASE A; GELATINASE B; SILYMARIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; CELL COUNT; CELL MOVEMENT; DIETHYLNITROSAMINE; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; SILYMARIN;

EID: 64649086559     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-008-9163-y     Document Type: Article

References (46)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108
2. HB El-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750
3. HB El-Serag AC Mason C Key 2001 Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States Hepatology 33 62 65
4. SS Hecht 1997 Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis Proc Soc Exp Biol Med 216 2 181 191
5. DH Fine R Ross DP Rounbehler A Silvergleid L Song 1977 Formation in vivo of volatile N-nitrosamines in man after ingestion of cooked bacon and spinach Nature 265 753 755
6. J Zhao R Agarwal 1999 Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention Carcinogenesis 20 11 2101 2108
7. H Kohno R Suzuki S Sugie H Tsuda T Tanaka 2005 Dietary supplementation with silymarin inhibits 3,2¢-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis in male F344 rats Clin Cancer Res 11 13 4962 4967
8. Ramakrishnan G, Muzio LL, Elinos-Baez CM, Jagan S, Augustine TA, Kamaraj S, Devaki T (2008) Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif (in press)
9. M Kaur R Agarwal 2007 Silymarin and epithelial cancer chemoprevention: how close are we to bedside? Toxicol Appl Pharmacol 224 3 350 359
10. G Ramakrishnan HR Raghavendran R Vinodhkumar T Devaki 2006 Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats Chem Biol Interact 161 2 104 114
11. G Ramakrishnan TA Augustine S Jagan R Vinodhkumar T Devaki 2007 Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats Exp Oncol 29 1 39 44
12. N Bhatia J Zhao DM Wolf R Agarwal 1999 Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin Cancer Lett 147 77 84
13. SK Katiyar 2005 Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects Int J Oncol 26 169 176
14. DE Kleiner WG Stetler-Stevenson 1993 Structural biochemistry and activation of matrix metalloproteinases Curr Opin Cell Biol 5 891 897
15. Y Uchima T Sawada K Hirakawa 2007 Action of antiproteases on pancreatic cancer cells JOP 8 4 Suppl 479 487
16. G Bergers K Javaherian K Lo J Folkman D Hanahan 1999 Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 284 808 812
17. ML Coussens B Fingleton LM Matrisian 2002 Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2387 2392
18. EI Deryugina JP Quigley 2006 Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 25 9 34
19. GL Brower AL Chancey S Thanigaraj BB Matsubara JS Janicki 2002 Cause and effect relationship between myocardical mast cell number and matrix metalloproteinase activity Am J Physiol Heart Circ Physiol 283 H518 H525
20. B Heissig S Rafii H Akiyama Y Ohki Y Sato T Rafael 2005 Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization J Exp Med 202 6 739 750
21. LM Coussens WW Raymond G Bergers M Laig-Webster O Bendrendtsen Z Werb 1999 Inflammatory mast cells up-regulated angiogenesis during squamous epithelial carcinogenesis Genes Dev 13 1382 1397
22. G Ranieri A Labriola G Achille G Florio AF Zito L Grammatica 2002 Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma Int J Oncol 21 6 1317 1323
23. SH Peng H Deng J Yang PP Xie C Li H Li 2005 Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues World J Gastroenterol 11 41 6521 6524
24. AJ Minn GP Gupta PM Siegel PD Bos W Shu DD Giri 2005 Genes that mediate breast cancer metastasis to lung Nature 436 518 524
25. E Gounaris SE Erdman C Restaino MF Gurish DS Friend F Gounari 2007 Mast cells are an essential hematopoietic component for polyp development Proc Natl Acad Sci USA 104 50 19977 19982
26. HR Rodewald M Dessing AM Dvorak SJ Galli 1996 Identification of a committed precursor for the mast cell lineage Science 271 818 822
27. E Dundar U Oner BC Peker M Metintas S Isiksoy G Ak 2008 The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma J Int Med Res 36 1 88 95
28. AB Rajput DA Turbin MC Cheang DK Voduc S Leung KA Gelmon 2008 Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases Breast Cancer Res Treat 107 2 249 257
29. F Grizzi B Franceschini M Chiriva-Internati Y Liu PL Hermonat N Dioguardi 2003 Mast cells and human hepatocellular carcinoma World J Gastroenterol 9 7 1469 1473
30. R DeLaPuerta E Martinez L Bravo MC Ahumada 1996 Effect of silymarin on different acute inflammation models and on leukocyte migration J Pharm Pharmacol 48 9 968 970
31. G Ramakrishnan CM Elinos-Baez S Jagan TA Augustine S Kamaraj P Anandakumar 2008 Silymarin downregulates COX-2 expression and attenuates hyperlipidaemia during NDEA induced rat hepatocellular carcinoma Mol Cell Biochem 313 1-2 53 61
32. JD Jia M Bauer JJ Cho M Ruehl S Milani G Boigk 2001 Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1 J Hepatol 35 3 392 398
33. M Zheng Y Ruan Z Wu 2000 Correlation study of TGF beta expression in diethylnitrosamine-induced rat liver cancer and mast cell in its vicinity Zhonghua Zhong Liu Za Zhi 22 6 463 465
34. E Tchnougounova A Lundequist I Fajardo J Winberg M Abrink G Pejler 2005 A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2 J Biol Chem 280 10 9291 9296
35. S Hiratsuka K Nakamura S Iwai M Murakami T Itoh H Kijima 2002 MMP-9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis Cancer Cell 2 4 289 300
36. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 174
37. LA Liotta K Tryggvason S Garbisa I Hart CM Foltz S Shatic 1980 Metastatic potential correlates with enzymatic degradation of basement-membrane collagen Nature 284 67 68
38. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 364
39. WG Stetler-Stevenson 1999 Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention J Clin Invest 103 1237 1241
40. CF Chantrian P Henriet S Jodele H Emonard O Feron PJ Courtoy 2006 Mechanisms of pericyte recruitment in tumor angiogenesis: a new role for metalloproteinases Eur J Cancer 42 3 310 318
41. LM Coussens CL Tinkle D Hanahan Z Werb 2000 MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 481 490
42. G Bergers R Brekken G [tmp] McMahon TH Vu T Itoh K Tamaki 2000 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat Cell Biol 2 737 744
43. T Itoh M Tanioka H Yoshida T Yoshioka H Nishimoto S Itohara 1998 Reduced angiogenesis and tumor progression in gelatinase A-deficient mice Cancer Res 58 1048 1051
44. ND Girolamo I Indoh N Jackson D Wakefield HP [tmp] McNeil W Yan 2006 Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration J Immunol 177 2638 2650
45. B Davidson V Givant-Horwitz P Lazarovici B Risberg JM Nesland CG Trope 2003 Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma Clin Exp Metastasis 20 7 621 631
46. RP Singh AK Tyagi J Zhao R Agarwal 2002 Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis Carcinogenesis 23 3 499 510